We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EOLS market cap is 810.63M. The company's latest EPS is USD -1.2842 and P/E is -10.89.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 33.9M | 43.65M | 41.72M | 49.35M | 50.02M |
Operating Income | -16.68M | -14.58M | -10.39M | -13.44M | -11.64M |
Net Income | -20.28M | -13.16M | -14.79M | -18.14M | -16.92M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 34.93M | 58.55M | 99.67M | 148.62M |
Operating Income | -46.14M | -98.95M | -153.07M | -69.91M | -65.33M |
Net Income | -46.87M | -90.03M | -163.01M | -46.81M | -74.41M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 192.72M | 177.98M | 160.24M | 168.98M | 167.97M |
Total Liabilities | 163.5M | 159.48M | 153.29M | 175.95M | 187.34M |
Total Equity | 29.22M | 18.5M | 6.95M | -6.96M | -19.37M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 171.84M | 240.44M | 209.07M | 257.48M | 177.98M |
Total Liabilities | 87.46M | 160.99M | 282.03M | 175.61M | 159.48M |
Total Equity | 84.38M | 79.46M | -72.96M | 81.88M | 18.5M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -76.14M | -84.91M | -20.59M | -33.9M | -34.82M |
Investing | -1.55M | -2.94M | -511k | -727k | -1.27M |
Financing | -2.63M | -4.15M | -1.28M | 22.54M | 21.12M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -25.67M | -93.38M | -57.87M | -33.39M | -84.91M |
Investing | -9k | -23.43M | 12.19M | 4.03M | -2.94M |
Financing | 118.86M | 133.55M | 38.35M | 73.05M | -4.15M |
Market Cap | 810.63M |
Price to Earnings Ratio | -10.89 |
Price to Sales Ratio | 5.45 |
Price to Cash Ratio | 15.03 |
Price to Book Ratio | 43.82 |
Dividend Yield | - |
Shares Outstanding | 57.94M |
Average Volume (1 week) | 679.52k |
Average Volume (1 Month) | 738.43k |
52 Week Change | 66.75% |
52 Week High | 15.4325 |
52 Week Low | 7.07 |
Spread (Intraday) | 0.95 (6.51%) |
Company Name | Evolus Inc |
Address |
838 walker road dover, delaware 19904 |
Website | https://www.evolus.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions